KCNK16 and Glucose intolerance: Taken together, the KcnK16 L114P mouse model shows disrupted glucagon and insulin secretion leading to fasting hyperglycemia and glucose intolerance, which provides confirmation that TALK-1 gain-of-function mutations likely cause MODY.